Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

23.00
Delayed Data
As of Dec 09
 +0.70 / +3.14%
Today’s Change
9.51
Today|||52-Week Range
26.84
+71.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues38.6M42.7M43.1M50.4M
 
 
 
 
 
Cost of Goods Sold2.0M2.5M1.6M2.1M
 
 
 
 
 
Depreciation And Amortization220.0K270.0K429.0K688.0K
 
 
 
 
 
 
Operating ExpensesGross Income36.3M39.9M41.0M47.7M
 
 
 
 
 
General Expenses32.0M33.0M35.7M37.2M
 
 
 
 
 
Research And Development9.1M9.4M10.6M11.1M
 
 
 
 
 
Total Operating Expenses34.3M35.8M37.8M40.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income4.3M6.8M5.3M10.4M
 
 
 
 
 
Extraordinary Credit114.0K189.0K101.0K123.0K
 
 
 
 
 
Extraordinary Charge-25.0K---382.0K0.00
 
 
 
Interest Expense On Debt292.0K225.0K179.0K196.0K
 
 
 
 
 
Other Expenses5.0K8.0K-4.0K2.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.3M7.0M5.2M10.7M
 
 
 
 
 
Income Taxes-58.0K-174.0K-198.0K-714.0K
 
 
 
 
 
Net Income4.2M6.9M5.0M10.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.5M48.9M49.2M49.4M
 
 
 
 
 
Shares To Calculate EPS Diluted51.6M49.6M51.2M51.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.08$0.14$0.08$0.18
 
 
 
 
 
EPS Diluted$0.08$0.14$0.08$0.18